These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36411644)

  • 1. Therapeutic potentials of modulating autophagy in pathological cardiac hypertrophy.
    Shi S; Jiang P
    Biomed Pharmacother; 2022 Dec; 156():113967. PubMed ID: 36411644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.
    Wang X; Cui T
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H304-H319. PubMed ID: 28576834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy.
    Zhou L; Ma B; Han X
    J Mol Endocrinol; 2016 Nov; 57(4):R143-R152. PubMed ID: 27620875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4.
    Song R; Lei H; Feng L; Cheng W; Li Y; Yao LL; Liu J
    J Biol Chem; 2021 Oct; 297(4):101189. PubMed ID: 34517007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological and pathological cardiac hypertrophy.
    Shimizu I; Minamino T
    J Mol Cell Cardiol; 2016 Aug; 97():245-62. PubMed ID: 27262674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy.
    Jin L; Zhou Y; Han L; Piao J
    In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):112-119. PubMed ID: 31845077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs as orchestrators of autophagic processes.
    Gupta SK; Thum T
    J Mol Cell Cardiol; 2016 Jun; 95():26-30. PubMed ID: 26654780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.
    Deng KQ; Zhao GN; Wang Z; Fang J; Jiang Z; Gong J; Yan FJ; Zhu XY; Zhang P; She ZG; Li H
    Circulation; 2018 Apr; 137(14):1486-1504. PubMed ID: 29229612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
    Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-103 inhibiting cardiac hypertrophy through inactivation of myocardial cell autophagy via targeting TRPV3 channel in rat hearts.
    Qi H; Ren J; E M; Zhang Q; Cao Y; Ba L; Song C; Shi P; Fu B; Sun H
    J Cell Mol Med; 2019 Mar; 23(3):1926-1939. PubMed ID: 30604587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of FNTB and the activation of Ras induce hypertrophy and promote apoptosis and autophagic cell death in cardiomyocytes.
    Ding J; Chen YX; Chen Y; Mou Y; Sun XT; Dai DP; Zhao CZ; Yang J; Hu SJ; Guo X
    J Cell Mol Med; 2020 Aug; 24(16):8998-9011. PubMed ID: 32579303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy.
    Kishore R; Krishnamurthy P; Garikipati VN; Benedict C; Nickoloff E; Khan M; Johnson J; Gumpert AM; Koch WJ; Verma SK
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):203-13. PubMed ID: 26549357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure.
    Yu P; Zhang Y; Li C; Li Y; Jiang S; Zhang X; Ding Z; Tu F; Wu J; Gao X; Li L
    J Cell Mol Med; 2015 Jul; 19(7):1710-9. PubMed ID: 25851780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of autophagic degradation in the heart.
    Nishida K; Taneike M; Otsu K
    J Mol Cell Cardiol; 2015 Jan; 78():73-9. PubMed ID: 25300865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of autophagy in pathological cardiac hypertrophy.
    Li Z; Wang J; Yang X
    Int J Biol Sci; 2015; 11(6):672-8. PubMed ID: 25999790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of autophagy in cardiac hypertrophy.
    Li L; Xu J; He L; Peng L; Zhong Q; Chen L; Jiang Z
    Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):491-500. PubMed ID: 27084518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM173 protects against pressure overload-induced cardiac hypertrophy by modulating autophagy.
    Jin YG; Zhou H; Fan D; Che Y; Wang ZP; Wang SS; Tang QZ
    J Cell Physiol; 2021 Jul; 236(7):5176-5192. PubMed ID: 33368294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bmi-1-RING1B prevents GATA4-dependent senescence-associated pathological cardiac hypertrophy by promoting autophagic degradation of GATA4.
    Chen H; Zhou J; Chen H; Liang J; Xie C; Gu X; Wang R; Mao Z; Zhang Y; Li Q; Zuo G; Miao D; Jin J
    Clin Transl Med; 2022 Apr; 12(4):e574. PubMed ID: 35390228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways.
    Sun M; Ouzounian M; de Couto G; Chen M; Yan R; Fukuoka M; Li G; Moon M; Liu Y; Gramolini A; Wells GJ; Liu PP
    J Am Heart Assoc; 2013 Apr; 2(2):e000191. PubMed ID: 23608608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septin localization and function during autophagy.
    Barve G; Sanyal P; Manjithaya R
    Curr Genet; 2018 Oct; 64(5):1037-1041. PubMed ID: 29651536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.